Remove Diet Remove Lipid disorders Remove Research
article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable risk factors. Key Takeaways: Up to 50% of all dementia cases could potentially be prevented or substantially delayed.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

A meta-analysis published in the Journal of Consulting and Clinical Psychology found that motivational interviewing effectively promoted behavior change across various health domains, including diet and exercise. This approach improves patient outcomes and enhances the efficiency and satisfaction of healthcare providers across specialties.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111